Who can receive funded Zostavax®?
- Adults aged 65 years
Catch up programme has ended.
A non-live recombinant zoster vaccine (Shingrix) is now available but not funded, for anyone from age 50 years, including those aged over 65 years.
Zostavax and annual influenza vaccination
- Annual influenza immunisation is recommended and funded for adults aged 65 years or over.
- One dose of Zostavax is recommended and also funded for adults aged 65 years.
- Zostavax and influenza vaccine can be administered at the same visit.
- Zostavax is only given as a single dose – it IS NOT administered every year that an eligible adult receives their influenza vaccination.
- When Zostavax and an influenza vaccination are administered to an eligible adult at the same visit from 1 April through 31 December:
- Please contact your PHO on how to claim for these events.
- Checklist for the shingles vaccine (Zostavax) for patients
- Prevention of herpes zoster (shingles) through immunisation
- Herpes zoster (shingles) factsheet
- Quick Answers: Recombinant Zoster Vaccine, rZV (Shingrix)
Hormonal cancer treatments and Zostavax
The following hormonal cancer treatments do not cause immunosuppression:
Trade – Generic name
Generic – Trade name
|Arimidex – Anastrazole||Anastrazole – Arimidex|
|Bicalox – Bicalutamide||Bicalutamide – Bicalox|
|Mestane – Exemestane||Cyproterone – Procur, Siterone|
|Letara – Letrozole||Exemestane – Mestane|
|Letrole – Letrozole||Goserelin – Zoladex|
|Procur – Cyproterone||Letrozole – Letara, Letrole|
|Siterone – Cyproterone||Tamoxifen – Tamoxifen|
|Tamoxifen – Tamoxifen|
|Zolodex – Goserelin|